OMIM ID:
Retinitis Pigmentosa 72
Alternate Names
Defective Genes
Clinical Characteristics
Ocular Features
The history and fundus findings are typical for classic retinitis pigmentosa with onset of symptoms in the 4th and 5th decades or earlier. Salt and pepper pigmentation may also be present. These consist of night blindness, decreased visual acuity, and constriction of visual fields. The fields are constricted to 10-30 degrees, and vision ranges from 20/25 to 20/40. Optic pallor is often present, the retinal vessels are narrowed and bone-spicule pigmentation has been described. Vitreous ‘condensation’ sufficient to obscure fundus details may be present. ERG responses are absent or substantially reduced. Heterozygotes have no symptoms or fundus abnormalities.
Systemic Features
No systemic features have been described.
Genetics
Inheritance
Homozygous mutations in the ZNF408 gene (11p11.2) are responsible for this condition. The product of this gene is a transcription factor highly expressed in fetal and adult retina and plays a role in vasculogenesis.
Heterozygous mutations in the same gene cause familial exudative vitreoretinopathy (FEVR6) (616468) described in one family with significant vitreal and retinal vascular disease.
Pedigree
In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent. Carriers with only one mutation, such as the parents, do not have clinical disease. Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.
In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent. Carriers with only one mutation, such as the parents, do not have clinical disease. Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.